Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Charles Packard
CONTACT
Lead
ReHeva Biosciences,Inc.
This is a Phase 1 open label dose ranging study to assess the safety and tolerability of oral RH324 in advanced non-small cell lung cancer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted